Navigation Links
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
Date:6/2/2009

th fistulizing CD.
  • Reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active UC who have had an inadequate response to conventional therapy.
  • Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage and improving physical function in patients with PsA.
  • Treatment of adult patients with chronic severe plaque PsO who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

  • REMICADE is unique among available anti-TNF biologic therapies. It is the only anti-TNF biologic administered directly by caregivers in the clinic or office setting. REMICADE is a two-hour infusion administered every 6 or 8 weeks (indication-dependent), following a standard induction regimen that requires treatment at weeks 0, 2 and 6. As a result, REMICADE patients may require as few as six treatments each year.

    Important Safety Information

    Only a doctor can recommend a course of treatment after checking a patient's health condition. A doctor should discuss any potential benefits and risks and help make the best treatment decision on a patient by patient basis. Like other medicines that affect the immune system, REMICADE can cause serious side effects such as lowering a patient's ability to fight infections. There are reports of serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Doctors should monitor closely for signs and symptoms of TB during treatment with REMICADE. Patients should discuss any concerns about their health and medical care with their doctor.

    Patients should let their doctors know if they have or e
    '/>"/>

    SOURCE Centocor Ortho Biotech Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
    2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
    3. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
    4. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
    5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
    6. New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohns Disease According to First-of-its Kind Study
    7. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
    10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... 2014  SI-BONE, Inc. ( San Jose, California ... use of the iFuse Implant System, ® a ... the sacroiliac (SI) joint, announced that Priority Health ( ... Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage ... states that the fusion procedure, which employs the iFuse ...
    (Date:8/20/2014)... 20, 2014 Northstar Global Business Services, ... months of hard work from many talented specialists, ... formulation and package design.  The new formulation for ... into the product due to overwhelming evidence of ... Snorenz Nighttime will also include these vitamins, as ...
    (Date:8/20/2014)... 20, 2014 The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
    Breaking Medicine Technology:SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
    (Date:8/21/2014)... 2014 Entries are now open for ... comprehensive national awards program totally dedicated to recognizing excellence ... executive leadership. The entry deadline is Oct. 17. , ... Insights™, the first and only national magazine entirely devoted ... , “We launched the HREI Insights Awards program last ...
    (Date:8/21/2014)... New York, New York (PRWEB) August 21, 2014 ... the Medical Cannabis Network that a company located in ... to be the only marijuana patient verification ... like to welcome this new entity to our growing ... due to our belief that these claims are inaccurate. ...
    (Date:8/21/2014)... Steven Reinberg HealthDay Reporter ... experimental drug shows promise in treating respiratory syncytial virus (RSV), ... "We are finally making major progress in being able to ... of serious viral pneumonia, second only to influenza virus," said ... the University of Tennessee College of Medicine in Memphis. ...
    (Date:8/21/2014)... ATLANTAStrongly influenced by their self-interest, humans do not ... consequences, researchers in Georgia State University,s Brains and ... that humans are less concerned than previously believed ... findings are published in the journal Brain ... unfairness is affected by their self-interest, indicating the ...
    (Date:8/21/2014)... 21, 2014 Competing in the “Best ... Greg” will screen on Monday, August 25th at 7 ... Film Festival. This festival is named in top festival ... Symphony, Sony Software, Avid, and Write Brothers. , The ... & LFX, located at 410 South Myrtle Avenue (showtimes: ...
    Breaking Medicine News(10 mins):Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:“Heavy Metal Greg,” a Music Talk Show by Gregory Graham, Will Screen at Action on Film International Film Festival on 08/25/2014 2
    ... begin meeting the ... on Monday, BOLINGBROOK, Ill., Jan. 11 The ... will officially open its doors on Monday,January 14. After ... and facility reviews from the Illinois,Department of Public Health ...
    ... to improve results, study says , , FRIDAY, Jan. ... allowing for spontaneous breathing -- the so-called "wake ... mechanical ventilators in intensive care units, a new ... from ventilators and should become common practice, the ...
    ... of antibodies may block human immunodeficiency virus (HIV)-1 infection ... HIV-1 vaccine. The findings, published by Cell Press in ... antibody induction appears to be a key and necessary ... recent failure of vaccines that stimulated only the T ...
    ... 11 Welcome to Consumer,Reports Health News ... ConsumerReports.org cover issues pertaining to the efficacy ... natural medicines),mental health, diet and nutrition, food ... products, rates the effectiveness and affordability of,prescription ...
    ... Health loss caused by type 2 diabetes will more ... most other major causes falls, according to new research ... The research, published in the January 7 edition of ... of disease and injury in Australia from 1993 to ...
    ... Life Brokerage Partners,announces three new carrier relationships ... With these new additions, Life Brokerage,Partners provides ... of the most,exclusive national insurance carriers and ... agency., New relationships with Midland National, ...
    Cached Medicine News:Health News:Adventist Bolingbrook Hospital Opens to the Public 2Health News:Dual Treatment Helps Wean Patients From Ventilators 2Health News:Dual Treatment Helps Wean Patients From Ventilators 3Health News:Uncovering the Achilles' heel of the HIV-1 envelope 2Health News:Consumer Reports Health News 2Health News:Consumer Reports Health News 3Health News:Consumer Reports Health News 4Health News:UQ research predicts type 2 diabetes explosion 2Health News:Life Brokerage Partners Adds New Insurance Carriers 2
    Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
    ... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
    ... Ultra Micro Shafts For Insertion Through ... For Light-Weight ... ,Curved Shafts For A More Comfortable Approach., ... ,Protective Cap Supplied For Protection Of Jaws ...
    The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
    Medicine Products: